Clinical Trials Logo

Clinical Trial Summary

A difference between dialysate and serum sodium concentration leads to diffusive sodium transfer across the dialyzer membrane. The consequences of diffusive sodium flux into the patient can be chronic sodium overload leading to overhydration, hypertension, cardiovascular disease, and other problems. Diffusive sodium flux out of the patient can lead to intradialytic blood pressure instability. A simple strategy for alignment of dialysate and serum sodium concentrations was implemented starting in April/May 2010 in order to minimize the problems particularly associated with chronic sodium overload.


Clinical Trial Description

The purpose of this database analysis is to assess the impact that this operational change has had in the short, medium and long term on key clinical and laboratory parameters in the patients, including blood pressure, body weight, interdialytic weight gain, serum electrolytes, intradialytic saline administration, missed treatments, hospitalizations, medication, inflammatory markers, etc. All subjects included in the final dataset will be matched with dialysis patients receiving treatment in other dialysis clinics of the Renal Research Institute who were not subject to the operational change. This will lead to the development of a matched cohort of equal size unexposed to dialysate to serum sodium alignment.

The analysis is planned to investigate treatment effects, and test the effects of dialysate to serum sodium alignment for interactions and associations between those laboratory and clinical parameters. The extent and magnitude of sodium alignment (the operational change) will also be assessed. ;


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01825590
Study type Observational
Source Renal Research Institute
Contact
Status Completed
Phase N/A
Start date May 2011
Completion date August 2014

See also
  Status Clinical Trial Phase
Recruiting NCT02263196 - The Efficacy of Alcohol After Betadine and Combination of Alcohol and Betadine on Inflammation Vascular Access Phase 1/Phase 2
Completed NCT01396980 - Microcirculation During Haemodialysis N/A
Completed NCT02513303 - Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Phase 3
Completed NCT02443376 - The Effects of Hemodialysis Session on Vascular Stiffness N/A
Completed NCT02558153 - RCT of Paclitaxel DEB Compared to Standard PTA in Dialysis Fistula N/A
Completed NCT00322322 - Early Administration of L-carnitine in Hemodialysis Patients Phase 3
Completed NCT02870829 - Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K Phase 2
Completed NCT00501956 - Intradialytic Parenteral Nutrition in Hemodialysis Patients Phase 4
Completed NCT02950389 - REmoval of Free Light Chains. A COmpaRison of Three Different dialyzERs N/A
Recruiting NCT02446535 - Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW? N/A
Completed NCT00568399 - Sodium Thiosulfate Treatment of Vascular Calcification in ESRD N/A
Recruiting NCT05425056 - A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery Phase 3
Completed NCT01278693 - Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients Phase 2
Completed NCT00732069 - Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis Phase 2
Completed NCT01147354 - Effect of Selenium Supplementation on Inflammatory,Oxidative and Nutritional Markers in Hemodialysis Patients Phase 3
Completed NCT02747966 - The Relationship Between the Flow of Arteriovenous Fistula and Cardiac Function in Haemodialysis Patients N/A